Center-Authored Papers

Filters: Author is Verstovsek, Srdan  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Tretinoin
Treatment Outcome
Thalidomide
Tefferi A, Verstovsek S, Barosi G, Passamonti F, Roboz GJ, Gisslinger H, Paquette RL, Cervantes F, Rivera CE, Deeg HJ et al..  2009.  Pomalidomide is active in the treatment of anemia associated with myelofibrosis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(27):4563-9. Abstract
Survival Rate
Remission Induction
Prospective Studies
Tefferi A, Verstovsek S, Barosi G, Passamonti F, Roboz GJ, Gisslinger H, Paquette RL, Cervantes F, Rivera CE, Deeg HJ et al..  2009.  Pomalidomide is active in the treatment of anemia associated with myelofibrosis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(27):4563-9. Abstract
Primary Myelofibrosis
Tefferi A, Verstovsek S, Barosi G, Passamonti F, Roboz GJ, Gisslinger H, Paquette RL, Cervantes F, Rivera CE, Deeg HJ et al..  2009.  Pomalidomide is active in the treatment of anemia associated with myelofibrosis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(27):4563-9. Abstract
Prednisone
Tefferi A, Verstovsek S, Barosi G, Passamonti F, Roboz GJ, Gisslinger H, Paquette RL, Cervantes F, Rivera CE, Deeg HJ et al..  2009.  Pomalidomide is active in the treatment of anemia associated with myelofibrosis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(27):4563-9. Abstract
Polymerase Chain Reaction
Oxides
Middle Aged
Male
Leukemia, Promyelocytic, Acute
Immunologic Factors
Tefferi A, Verstovsek S, Barosi G, Passamonti F, Roboz GJ, Gisslinger H, Paquette RL, Cervantes F, Rivera CE, Deeg HJ et al..  2009.  Pomalidomide is active in the treatment of anemia associated with myelofibrosis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(27):4563-9. Abstract
Humans
Hematinics
Tefferi A, Verstovsek S, Barosi G, Passamonti F, Roboz GJ, Gisslinger H, Paquette RL, Cervantes F, Rivera CE, Deeg HJ et al..  2009.  Pomalidomide is active in the treatment of anemia associated with myelofibrosis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(27):4563-9. Abstract
Glucocorticoids
Tefferi A, Verstovsek S, Barosi G, Passamonti F, Roboz GJ, Gisslinger H, Paquette RL, Cervantes F, Rivera CE, Deeg HJ et al..  2009.  Pomalidomide is active in the treatment of anemia associated with myelofibrosis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(27):4563-9. Abstract
Follow-Up Studies
Female
Drug Administration Schedule
Double-Blind Method
Tefferi A, Verstovsek S, Barosi G, Passamonti F, Roboz GJ, Gisslinger H, Paquette RL, Cervantes F, Rivera CE, Deeg HJ et al..  2009.  Pomalidomide is active in the treatment of anemia associated with myelofibrosis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(27):4563-9. Abstract